U.S. Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse announces the availability of funding for implementation of the Exploratory Studies of Smoking Cessation Interventions for People With Schizophrenia (R33) Grant. The R33 funding mechanism intends to speed the translation of emerging basic science findings of mechanisms and processes underlying treatments or implementation strategies into novel intervention approaches that can be efficiently tested for their promise to promote smoking cessation in individuals who have schizophrenia or promote the adoption of experimentally-supported smoking cessation interventions within organizations that provide services to smokers with . . .